Zhende Medical Co., Ltd. (603301.SS)
CNY 19.14
(-0.05%)
CNY 19.14
(-0.05%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 4.12 Billion CNY | -32.76% |
| 2022 | 6.13 Billion CNY | 20.54% |
| 2021 | 5.09 Billion CNY | -51.04% |
| 2020 | 10.39 Billion CNY | 456.75% |
| 2019 | 1.86 Billion CNY | 30.71% |
| 2018 | 1.42 Billion CNY | 9.37% |
| 2017 | 1.3 Billion CNY | 26.24% |
| 2016 | 1.03 Billion CNY | 1.36% |
| 2015 | 1.02 Billion CNY | 3.45% |
| 2014 | 986.91 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 1.07 Billion CNY | 1.58% |
| 2024 Q1 | 963.88 Million CNY | 5.02% |
| 2024 Q2 | 1.06 Billion CNY | 10.6% |
| 2023 Q3 | 903.05 Million CNY | -10.2% |
| 2023 FY | 4.12 Billion CNY | -32.76% |
| 2023 Q1 | 1.3 Billion CNY | -32.97% |
| 2023 Q2 | 1 Billion CNY | -22.67% |
| 2023 Q4 | 917.84 Million CNY | 1.64% |
| 2022 FY | 6.13 Billion CNY | 20.54% |
| 2022 Q3 | 1.43 Billion CNY | -4.77% |
| 2022 Q4 | 1.94 Billion CNY | 35.62% |
| 2022 Q2 | 1.5 Billion CNY | 18.77% |
| 2022 Q1 | 1.26 Billion CNY | 2.92% |
| 2021 FY | 5.09 Billion CNY | -51.04% |
| 2021 Q3 | 950.54 Million CNY | 3.59% |
| 2021 Q4 | 1.22 Billion CNY | 29.29% |
| 2021 Q1 | 1.99 Billion CNY | -12.59% |
| 2021 Q2 | 917.56 Million CNY | -54.0% |
| 2020 Q4 | 2.28 Billion CNY | -46.89% |
| 2020 FY | 10.39 Billion CNY | 456.75% |
| 2020 Q1 | 709.13 Million CNY | 21.75% |
| 2020 Q2 | 3.11 Billion CNY | 338.66% |
| 2020 Q3 | 4.29 Billion CNY | 38.13% |
| 2019 FY | 1.86 Billion CNY | 30.71% |
| 2019 Q4 | 582.46 Million CNY | 11.33% |
| 2019 Q3 | 523.19 Million CNY | 22.21% |
| 2019 Q2 | 428.1 Million CNY | 28.19% |
| 2019 Q1 | 333.96 Million CNY | -16.67% |
| 2018 Q4 | 400.77 Million CNY | 10.4% |
| 2018 FY | 1.42 Billion CNY | 9.37% |
| 2018 Q1 | 279.95 Million CNY | -22.13% |
| 2018 Q2 | 385.12 Million CNY | 37.57% |
| 2018 Q3 | 363 Million CNY | -5.74% |
| 2017 Q2 | 318.35 Million CNY | 8.78% |
| 2017 Q1 | 292.66 Million CNY | 0.0% |
| 2017 FY | 1.3 Billion CNY | 26.24% |
| 2017 Q3 | 335.91 Million CNY | 5.52% |
| 2017 Q4 | 359.49 Million CNY | 7.02% |
| 2016 FY | 1.03 Billion CNY | 1.36% |
| 2015 FY | 1.02 Billion CNY | 3.45% |
| 2014 FY | 986.91 Million CNY | 0.0% |